Leadership

Scientific Advisory Board

Stuart A. Montgomery, B.SC., MD. F.R.C. Psych. — Dr. Montgomery has been a member of the Scientific Advisory Board since March 1994. He developed the Montgomery Asberg scale for the evaluation and treatment of depression. Since 1981, Dr. Montgomery has served as a psychiatry professor and a consultant psychiatrist at St. Mary's Hospital Medical School, London, England. Since 1992, Dr. Montgomery has served as the President of the European College of Neuropsychopharmacology. From 1990 to 1992, Dr. Montgomery was a member of the Royal College of Psychiatrists in London, England. He is editor of International Clinical Pharmacology and European Neuropsychophannacology, and has published extensively. Dr. Montgomery received a B.SC. from the University of London in 1960 and completed his medical degree in 1963 with an MBBS from the University College Hospital, University of London. He was awarded an M.D. as a research doctorate (Ph.D.) from Karolinska Institute, Stockholm (1978). He holds a diploma of Psychological Medicine from the Royal College of Physicians and Surgeons, London (1973) and a membership of Royal College of Psychiatrists, London (1974). He was made a Fellow of the Royal College of Psychiatrists, London (1984).

Karl Rickels, MD. — Dr. Rickels has been a member of the Scientific Advisory Board since March, 1994. From 1972-1975, Dr. Rickels served as chairman of the FDA's advisory review panel on over-the-counter daytime and nighttime sedatives and stimulant products. Since 1957, Dr. Rickels has served as a member of various departmental faculties of the University of Pennsylvania. Since 1964, Dr. Rickels has been appointed to serve in various hospital and administrative positions for the Hospital of the University of Pennsylvania, the Philadelphia General Hospital, and the University of Pennsylvania. From 1975-1977; Dr. Rickels was Chairman of the Department of Psychiatry at the Philadelphia General Hospital. Dr. Rickels has been the Stuart and Emily B.H. Mudd Professor of Human Behavior since 1977 and a Professor of Psychiatry at the University of Pennsylvania, Department of Psychiatry, since 1969. He completed his medical internship at Dortmund Hospital in Germany in 1952, post-graduate training at the Universities of Erlangen and Frankfurt in 1954, and a residency in psychiatry at the Hospital of the University of Pennsylvania in 1957. Dr. Rickels was awarded an Abitur degree in 1942 at Berlin-Lichtenberg and an M.D. in 1951 from Muenster University, Germany. Dr. Rickels has published more than 480 scientific publications, abstracts, chapters and books.

Davis L. Temple, Jr., Ph.D. — Dr. Temple has been a member of the Scientific Advisory Board since March 1994. Dr. Temple has more than 20 years of experience in the area of pharmaceutical research and development. Prior to January 1994, Dr. Temple was Vice President, Central Nervous System Drug Discovery at BMS. Dr. Temple's various responsibilities at BMS included the management of diverse areas of research and development, including molecular biology, biophysics and clinical research. He also conducted several major clinical development programs, and is credited as the inventor of Gepirone on the U.S. Patent. Dr. Temple is the author of more than 100 publications in the areas of medicinal chemistry, neurosciences, and is named on numerous U.S. Patents. Dr. Temple consults extensively for the biotechnology and pharmaceutical industry. He received his B.S. in pharmacy and his Ph.D. in medicinal chemistry from the University of Mississippi, and was a post-doctoral fellow at Louisiana State University.